Cutaneous aspergillosis in a patient with follicular lymphoma.

Sir, We read with great interest the article by Nenoff et al., reporting a case of secondary cutaneous aspergillosis (CA) developing during therapy against acute leukemia [1]. CA has been considered a very rare entity, although it has been recognized as one of the nosocomial infections arising in immunocompromised patients [2-6]. However, with an increasing number of immunocompromised patients, including those with acquired immunodeficiency [...]